Showing results (891-900 of 4,380) with videos related to
Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|March 20, 2024
Discovery and Characterization of Active CBP/EP300 Degraders Targeting the HAT DomainIván Cheng-Sánchez, Katherine A Gosselé, Leonardo Palaferri, et al.ACS Medicinal Chemistry Letters|July 17, 2024
8-l-Cystinyl Bis(1,8-diazaspiro[4.5]decane) as an Orally Bioavailable l-Cystine Crystallization Inhibitor for CystinuriaLongqin Hu, Haifa Albanyan, Jeffrey Yang, et al.ACS Medicinal Chemistry Letters|July 17, 2024
Advancements in Protein Degradation for Cancer TherapyRobert B KargboACS Medicinal Chemistry Letters|July 17, 2024
Optimization of Novel Pyrido-pyridazinone Derivatives as FER Tyrosine Kinase Inhibitors, Leading to the Potent DS08701581Toru Taniguchi, Isao Yasumatsu, Hiroaki Inagaki, et al.ACS Medicinal Chemistry Letters|July 17, 2024
Investigation of Isobactin Analogues of TeixobactinChelsea R Jones, Grant H Lai, Maria Sophia Teresa Lee Padilla, et al.ACS Medicinal Chemistry Letters|July 17, 2024
Synthesis and Evaluation of 1,3-Disubstituted Imidazolidine-2,4,5-triones as Inhibitors of Pyruvate CarboxylaseNicholas O Schneider, Kendra Gilreath, Niel M Henriksen, et al.ACS Medicinal Chemistry Letters|January 17, 2024
Synthesis and Evaluation of Benzylamine Inhibitors of Neuropathogenic Naegleria fowleri "Brain-Eating" AmoebaJulia M Pomeroy, Muhammad M Khalifa, Jillian E Milanes, et al.ACS Medicinal Chemistry Letters|January 17, 2024
MDM2 Antagonist Idasanutlin Reduces HDAC1/2 Abundance and Corepressor Partners but Not HDAC3Joshua P Smalley, Shaun M Cowley, James T HodgkinsonACS Medicinal Chemistry Letters|September 18, 2024
Quinolinonyl Derivatives as Dual Inhibitors of the HIV-1 Integrase Catalytic Site and Integrase-RNA interactionsElisa Patacchini, Valentina Noemi Madia, Aurora Albano, et al.ACS Medicinal Chemistry Letters|September 18, 2024
SAR Study of 4,8-Disubstituted Pyrimido[5,4-d]pyrimidines Exhibiting Antitrypanosomal and Antileishmanial ActivityAndré Lopes, Sofia Teixeira, Nuno Santarém, et al.Pageof 438